18:15:16 EDT Fri 18 Jun 2021
Enter Symbol
or Name

Login ID:
Delta 9 Cannabis Inc
Symbol DN
Shares Issued 101,940,350
Close 2021-02-10 C$ 0.66
Recent Sedar Documents

Delta 9 Cannabis expects Q4 sales of $13.95-million

2021-02-10 18:17 ET - News Release

Mr. John Arbuthnot reports


Delta 9 Cannabis Inc. has provided guidance on select fourth quarter and year-end results ending Dec. 31, 2020, based on preliminary results:

  • The company anticipates net revenues for the three-month period ending Dec. 31, 2020, to be between $13.7-million and $14.2-million. This compares with:
    • $10.6-million for the same period in 2019, an increase of between 29 per cent and 34 per cent;
    • $13.1-million sequentially from the third quarter of 2020, an increase of between 5 per cent and 8 per cent.
  • The company anticipates revenues for the year ending Dec. 31, 2020, to be between $51.8-million and $52.3-million, compared with $31.8-million for the same period in the prior year.
  • The company anticipates reporting direct cannabis production cost per gram of 67 cents and total cost per gram of 80 cents for the fourth quarter of 2020, compared with 74 cents and 86 cents respectively for the third quarter of 2020.
  • The company anticipates reporting total grams of cannabis produced of 2,128,288 for the fourth quarter of 2020, compared with 1,908,875 grams of cannabis for the third quarter of 2020.
  • The company anticipates reporting total retail transactions processed of 202,347 for the fourth quarter of 2020, compared with 184,750 for the third quarter of 2020.

"We are anticipating reporting record year-over-year and sequential revenue results for the fourth quarter of 2020," said John Arbuthnot, chief executive officer of Delta 9. "Delta 9 is working to separate itself from its peers by posting strong financial and operating results and continuing to grow its revenue streams from its three core business units."

Delta 9 will provide investors with a full breakdown on its progress in these areas as a part of its year-end and fourth quarter results, which will be released on March 30, 2021, before markets open, followed by a conference call, details for which can be found at the end of this release.

The preliminary estimated financial results and other data for the three-month period and year ended Dec. 31, 2020, set forth above are unaudited and subject to the completion of the company's financial closing procedures. These preliminary estimated financial results have been prepared by and are the responsibility of the company's management. The company's independent registered public accounting firm, Baker Tilly HMA LLP, is in the process of performing year-end audit procedures with respect to the accompanying preliminary financial results and other data, and accordingly does not express an opinion or any other form of assurance with respect thereto.

The company currently expects that its final results of operations and other data will be consistent with the estimates set forth above, but such estimates are preliminary and the company's actual results of operations and other data could differ materially from these estimates due to the completion of its financial closing procedures, final adjustments and other developments that may arise between now and the time such consolidated financial statements for the period ended Dec. 31, 2020, are issued.

2020 year-end results conference call

Delta 9 will release the results for its year end on March 30, 2021. A conference call to discuss the above results is scheduled for March 30, 2021, premarket. The conference call will be hosted that day at 9 a.m. ET by John Arbuthnot, chief executive officer, and Jim Lawson, chief financial officer, followed by a question-and-answer period.

Date:  March 30, 2021

Time:  9 a.m. ET

Dial-in number:  1-888-886-7786

Replay:  1-877-674-6060; available until midnight ET, June 30, 2021

Replay passcode:  641689 followed by the pound key

© 2021 Canjex Publishing Ltd. All rights reserved.